DE vs JNJ: Which Is the Better Buy?

Side-by-side comparison of Deere & Company and Johnson & Johnson โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Deere & Company ยท Industrials
$703.12
-12.2% upside to fair value
Med Conviction Grade C High Quality
VS
Johnson & Johnson ยท Healthcare
$270.68
+5.7% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
JNJ has more upside to fair value (+5.7%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric DE JNJ
Current Price $703.12 $270.68
Fair Value Estimate $616.99 $286.05
Upside to Fair Value -12.2% +5.7%
Market Cap $189.8B $652.3B
Forward P/E โ€” โ€”
EV / EBITDA 22.1x 20.2x
Price / Sales 4.0x 6.7x
Price / FCF 49.1x 35.3x
Revenue Growth YoY +7.0% +6.6%
Gross Margin 35.7% 67.9%
Operating Margin 19.0% 26.8%
Return on Equity 18.1% 25.7%
Dividend Yield 0.92% 1.95%
FCF Yield 2.04% 2.83%
Analyst Consensus Buy Buy
Investment Thesis
DE โ€” Deere & Company
Deere & Company is a 1837-founded global manufacturer of agricultural, turf, and construction equipment organized across Production and Precision Agriculture, Small Agriculture and Turf, Construction and Forestry, and Financial Services, employing roughly 73,100 people under CEO John C. May. Business quality is high on franchise strength but currently strained by the large-agriculture cycle: TTM โ€ฆ
JNJ โ€” Johnson & Johnson
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:โ€ฆ
Accumulation Zones
Metric DE JNJ
Zone Low $462.74 $214.54
Zone High $524.44 $243.14
In Buy Zone? No No
โ† DE Research    JNJ Research โ†’    All Research